Clinical Trial

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Study acronym: ELDAPT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
There is no detailed information available on benefits and harms of intensified treatment with concurrent RCHT among a subpopulation of elderly patients. Reliable tools are needed to distinguish the subgroup of fit patients from frail patients.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2014-11-05; most recent amendment 2025-07-02.
Status change: Recruiting → Active, Not Recruiting 2025-01-15
Status change: Not Yet Recruiting → Recruiting 2017-08-30
Trial Details
NCT Number NCT02284308
Lead Sponsor Maastricht Radiation Oncology
Collaborators: Dutch Society of Physicians for Pulmonology and Tuberculosis, Erasmus Medical Center, VieCuri Medical Centre, AstraZeneca, Dutch Cancer Society
Conditions NSCLC
Enrollment 180 participants
Start Date 2016-07
Primary Completion 2025-01-01 (estimated)
Study Completion 2029-12-18 (estimated)
Updated on ClinicalTrials.gov 2025-07-04